LifeNome Inc. | LinkedIn (original) (raw)

Biotechnology Research

New York, NY 1,420 followers

Precision Health and Genomics AI Platform

View all 16 employees

About us

LifeNome is a precision (biology-personalized) health platform powered by Genomics AI (c). We leverage systems-biology, multi-omics, and proprietary artificial intelligence to personalize health and wellbeing services and products of healthcare, insurance, pharmaceutical, nutrition, and fitness organizations worldwide. Our focus areas include precision preventive health (disease screening and intervention design), precision maternal and family health, and precision nutrition, and wellbeing. Awards and Recognitions: - LG Select 10 ($2 Million) - PEPSICO $100K Top Prize Food Tech Accelerator - Best Enterprise Precision Health and Wellness Platform (Biotech Awards, 2021) - Top Personalized Health Startup (Lux Research, 2020) - Top 20 Transformational Digital Health Startups (Lux Research, 2020) - Abbott Global Health Challenge Winner (from over 100 startups) - World Economic Forum Global Innovator Company (2020) - PEPSICO Greenhouse Accelerator Finalist (Top 10 out of 185) (2020) - Global winner Zurich World Innovation Championship (2019) - Top 10 AI Companies in Health (Analytics Insight, 2019) - Finalist in NVIDIA Inception Accelerator (2018) - Johnson and Johnson Quickfire (2018) - COTY Incubator Awards (2018) - Ranked Top Health DNA Company (DNA Testing Choice, 2017) - Top 10 AI Companies in Health (Disruptor Daily 2017) - Top 3 AI Companies (out of 135) (Bosch Venture Forum, 2017) - Top 10 Genomics Solutions Providers (PharmaTech 2017) - Key player in Genomics 2.0 (UBS, 2016)

Industry

Biotechnology Research

Company size

11-50 employees

Headquarters

New York, NY

Type

Privately Held

Founded

2016

Specialties

Bioinformatics, Personal Genomics, Biotechnology, Genomics 2.0, and Precision Nutrition

Locations

Employees at LifeNome Inc.

Updates

LifeNome was honored to host the 2024 Precision Health Summit, where Alfredo Carvajal shared inspiring insights on how Latin America is advancing healthcare through precision health. With the region’s ambitious goal of sequencing one million genomes, Latin America is creating a robust genomic database aimed at providing personalized, culturally sensitive care, especially for underserved indigenous communities. This groundbreaking approach is not only transforming medicine but also reshaping healthcare delivery to better meet local needs. AI-driven diagnostics are playing a key role in making healthcare more affordable, with cost reductions of up to 40%. Telemedicine is also helping bridge healthcare access gaps, bringing high-quality care to remote and rural areas. In addition, wellness-focused residential communities are emerging, integrating telemedicine and health-monitoring spaces, and meeting the growing demand for proactive, accessible healthcare. A cornerstone of Latin America’s progress is its commitment to training healthcare professionals in genomics and data science, ensuring that local expertise grows alongside these advancements. Mobile health solutions are bringing real-time care to remote communities, extending the reach of healthcare services to those who need it most. LifeNome looks forward to continuing its collaboration with Alfredo Carvajal and other leaders across Latin America to drive the future of precision health. Together, we can advance personalized, affordable, and accessible healthcare for all. We are excited to be part of this transformative journey. For more insights, visit https://lnkd.in/e3f4Tgra #PrecisionHealth #AccessibleHealthcare #Genomics #Telemedicine #HealthcareInnovation #LatAm Ali Mostashari, Ph.D, Raya Khanin, LifeNome
LifeNome Inc. was thrilled to host the Precision Health Summit 2024 with 1BusinessWorld , where Willie T. Reaves Jr., Head of Public Engagement at Cellino, shared his visionary perspective on the future of healthcare. Reaves discussed the transformative potential of personalized regenerative medicine and its ability to extend healthspan for all. By leveraging the power of induced pluripotent stem cells (iPSCs) derived from a patient's own blood, he emphasized how therapies can be tailored to treat chronic conditions like macular degeneration, Parkinson’s disease, and spinal cord injuries, all without the risk of immune rejection. Reaves highlighted the significant advantages of this approach, including avoiding the need for lifelong immunosuppression and ensuring treatments are accessible across diverse ethnic backgrounds. He also acknowledged the challenges in scaling up manufacturing but expressed optimism in overcoming these hurdles with innovations in automation and artificial intelligence, which can reduce costs and make these advanced treatments more widely available. A key message from Reaves was his call to action for the healthcare industry to prioritize addressing health disparities. He stressed that the development of these groundbreaking technologies should not be limited to the wealthy but should be available to everyone. Reaves called on industry leaders to invest in the necessary technologies, form strategic partnerships, and cultivate a skilled workforce to make these treatments accessible to all populations. We are excited to explore opportunities for collaboration between LifeNome and Cellino Bio, working together to advance personalized healthcare and bring innovative therapies to those who need them most. Thank you, Reaves, for your insightful contribution to the Summit. We look forward to seeing the future of healthcare unfold. #healthspan #personalizedmedicine #regenerativemedicine #precisionhealth #CellinoBio #innovativetherapies #healthcaretransformation #healthdisparities #futureofmedicineWATCH THE VIDEO OF THE here SESSION HERE:https://lnkd.in/ep_WHd5b Ali Mostashari, Ph.D
1,420 followers
1w Edited
We at LifeNome were thrilled to host this transformative event, bringing together leaders from venture capital, life sciences, and healthcare innovation to explore the future of precision health. Our latest newsletter dives deep into the key discussions and investment opportunities that emerged, featuring insights from industry experts such as: We explore vital areas like personalized supplements, fitness, beauty, longevity, maternal health, genomics, meal delivery, and precision medicine. Plus, learn more about LifeNome's offerings and how we can help you navigate this evolving landscape. Read the full newsletter to discover how these experts are navigating this dynamic landscape and learn more about LifeNome's innovative solutions#PrecisionHealth #LifeNome #HealthcareInnovation #InvestmentOpportunities #PersonalizedHealth #healthcare Dr. D. Martin Alexander Gershon, MD, JD, MPH Arda Ural,Pooja Majmudar, PhD, Ali
Transforming The Investment Landscape for Precision Health LifeNome Inc. on LinkedIn
1,420 followers
1w Edited
We’re proud to have LifeNome Inc. host the Precision Health Summit 2024, gathering industry leaders in investment and healthcare innovation to explore the immense potential of precision health. This transformative field, driven by advancements in artificial intelligence, genomics, and personalized medicine, aims to deliver targeted, data-driven treatments that are both effective and resource-efficient. Precision health has evolved beyond speculation, now representing a significant opportunity for investors seeking impactful returns alongside societal benefits. The investment landscape is rapidly shifting, with experts like Dr. D. Martin Alexander Gershon, Endeavor Venture Fund & Venture Studio and Arda Ural,of EY highlighting the importance of long-term strategies and disciplined financial management. They emphasized the critical role of regulatory support—especially from the FDA—in advancing this vital sector. Discussions also underscored the necessity of addressing broader health determinants, such as lifestyle and socioeconomic factors, to maximize the impact of precision health initiatives. Pooja Majmudar, PhD from Keles highlighted the integration of AI-driven solutions into practical healthcare, while Allan Gobbs from ATEM Capital noted that cross-border partnerships are essential for scaling innovations effectively. As global healthcare needs continue to grow, precision health offers unique opportunities for leaders committed to sustainable, transformative growth. The summit serves as a platform for aligning investment strategies with healthcare innovation, positioning participants to shape the future of medical advancement.https://lnkd.in/gQzDS2Mx #PrecisionHealth #LifeNome #InvestmentLandscape #PersonalizedMedicine #HealthTech #HealthcareInnovation Ali Mostashari, Ph.D 1BusinessWorld

Join now to see what you are missing

Join now

LifeNome Inc. | LinkedIn (original) (raw)

Biotechnology Research

New York, NY 1,420 followers

Precision Health and Genomics AI Platform

About us

Locations

Employees at LifeNome Inc.

Updates

Join now to see what you are missing

Affiliated pages

Similar pages

Browse jobs